International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10437585
Original Article
The Effect of Docosahexaenoic Acid (DHA) Supplementation On Serum Folate Levels In Underweight Pregnant Women
 ,
 ,
Published
Dec. 28, 2023
Abstract

Background: According to RISKESDAS in 2018, the prevalence of pregnant women at risk of Chronic Energy Deficiency (CED) in Indonesia was 17.3%. CED is a part of the underweight that needs to be addressed efficiently to prevent nutritional disorders. During pregnancy, one crucial nutrient is folate, which plays a role in preventing congenital defects and contributes to neurocognitive function. This study identifies the influence of DHA supplementation on serum folate levels in underweight pregnant women at the Made Surabaya Community Health Center.

Methods: The research follows a pre-experimental design with a one-group pre-and-post-test using 21 samples of underweight pregnant women. Physical examinations, obstetric assessments, ultrasonography, and venous blood collection for analysis were conducted before and after DHA supplementation.

Results: In this study, significant differences were found in underweight pregnant women before and after DHA supplementation in various parameters, namely body weight 51.76 ± 7.635 vs. 53.25 ± 7.310 (p = 0.018), BMI 22.171 ± 2.8173 vs. 22.814 ± 2.5908 (p = 0.034), UAC 24.238 ± 1.4545 vs. 25.243 ± 2.2288 (p = 0.003), folic acid 14.381 ± 4.8078 vs. 18.176 ± 5.8085 (p = 0.000), and fundal height 17.38 ± 7.606 vs. 19.14 ± 7.323 (p = 0.007).

Conclusions: The study found a significant influence on body weight, BMI, UAC, folic acid, and fundal height before and after DHA supplementation

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
799 Views
450 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved